Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, May 2000, p. 1209-1213, Vol. 44, No. 5
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Comparison of High-Performance Liquid
Chromatographic and Microbiological Methods for Determination of
Voriconazole Levels in Plasma
Sofia
Perea,1,*
Gennethel J.
Pennick,1
Asha
Modak,1
Annette W.
Fothergill,1
Deanna A.
Sutton,1
Daniel J.
Sheehan,2 and
Michael
G.
Rinaldi1,3
Department of Pathology, University of Texas
Health Science Center at San Antonio,1 and
Audie Murphy Division, South Texas Veterans Health Care
System,3 San Antonio, Texas, and
Pfizer Pharmaceutical Group, Pfizer Inc., New York, New
York2
Received 2 August 1999/Returned for modification 7 November
1999/Accepted 28 January 2000
A new selective high-performance liquid chromatography (HPLC)
method with UV detection for the determination of the investigational triazole voriconazole in human plasma by using acetonitrile
precipitation followed by reverse-phase HPLC on a C18
column was compared with a simple agar well diffusion bioassay method
with Candida kefyr ATCC 46764 as the assay organism. Pooled
plasma was used to prepare standard and control samples for both
methods. The results of analyses with spiked serum samples (run as
unknowns) were concordant by the bioassay and HPLC methods, with
expected values being obtained. HPLC demonstrated an improved precision
(3.47 versus 12.12%) and accuracy (0.81 versus 1.28%) compared to
those of the bioassay method. The range of linearity obtained by both
methods (from 0.2 to 10 µg/ml for HPLC and from 0.25 to 20 µg/ml
for the bioassay) includes the range of concentrations of voriconazole
(from 1.2 to 4.7 µg/ml) which are considered clinically relevant.
Although either methodology could be used for the monitoring of patient therapy, the smaller variability observed with HPLC compared to that
observed with the bioassay favors the use of HPLC for pharmacokinetic studies.
*
Corresponding author. Department of Medicine/Division
of Infectious Diseases, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., Mail Code 7881, San Antonio, TX
78229-3900. Phone: (210) 5671981. Fax: (210) 5673303. E-mail: Perea{at}UTHSCSA.EDU.
Antimicrobial Agents and Chemotherapy, May 2000, p. 1209-1213, Vol. 44, No. 5
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Kahle, K., Langmann, P., Schirmer, D., Lenker, U., Keller, D., Helle, A., Klinker, H., Heinz, W. J.
(2009). Simultaneous Determination of Voriconazole and Posaconazole Concentrations in Human Plasma by High-Performance Liquid Chromatography. Antimicrob. Agents Chemother.
53: 3140-3142
[Abstract]
[Full Text]
-
Craig, W. A., Andes, D. R.
(2008). In Vivo Pharmacodynamics of Ceftobiprole against Multiple Bacterial Pathogens in Murine Thigh and Lung Infection Models. Antimicrob. Agents Chemother.
52: 3492-3496
[Abstract]
[Full Text]
-
Pai, M. P., Samples, M. L., Mercier, R.-C., Spilde, M. N.
(2008). Activities and Ultrastructural Effects of Antifungal Combinations against Simulated Candida Endocardial Vegetations. Antimicrob. Agents Chemother.
52: 2367-2376
[Abstract]
[Full Text]
-
Goodwin, M. L., Drew, R. H.
(2008). Antifungal serum concentration monitoring: an update. J Antimicrob Chemother
61: 17-25
[Abstract]
[Full Text]
-
Vemulakonda, G. A., Hariprasad, S. M., Mieler, W. F., Prince, R. A., Shah, G. K., Van Gelder, R. N.
(2008). Aqueous and Vitreous Concentrations Following Topical Administration of 1% Voriconazole in Humans. Arch Ophthalmol
126: 18-22
[Abstract]
[Full Text]
-
Pascual, A., Nieth, V., Calandra, T., Bille, J., Bolay, S., Decosterd, L. A., Buclin, T., Majcherczyk, P. A., Sanglard, D., Marchetti, O.
(2007). Variability of Voriconazole Plasma Levels Measured by New High-Performance Liquid Chromatography and Bioassay Methods. Antimicrob. Agents Chemother.
51: 137-143
[Abstract]
[Full Text]
-
Khoschsorur, G., Fruehwirth, F., Zelzer, S.
(2005). Isocratic High-Performance Liquid Chromatographic Method with Ultraviolet Detection for Simultaneous Determination of Levels of Voriconazole and Itraconazole and Its Hydroxy Metabolite in Human Serum. Antimicrob. Agents Chemother.
49: 3569-3571
[Abstract]
[Full Text]
-
Hariprasad, S. M., Mieler, W. F., Holz, E. R., Gao, H., Kim, J. E., Chi, J., Prince, R. A.
(2004). Determination of Vitreous, Aqueous, and Plasma Concentration of Orally Administered Voriconazole in Humans. Arch Ophthalmol
122: 42-47
[Abstract]
[Full Text]
-
Pennick, G. J., Clark, M., Sutton, D. A., Rinaldi, M. G.
(2003). Development and Validation of a High-Performance Liquid Chromatography Assay for Voriconazole. Antimicrob. Agents Chemother.
47: 2348-2350
[Abstract]
[Full Text]
-
Nulens, E., Eggink, C., Rijs, A. J. M. M., Wesseling, P., Verweij, P. E.
(2003). Keratitis Caused by Scedosporium apiospermum Successfully Treated with a Cornea Transplant and Voriconazole. J. Clin. Microbiol.
41: 2261-2264
[Abstract]
[Full Text]
-
Lewis, R. E., Kontoyiannis, D. P., Darouiche, R. O., Raad, I. I., Prince, R. A.
(2002). Antifungal Activity of Amphotericin B, Fluconazole, and Voriconazole in an In Vitro Model of Candida Catheter-Related Bloodstream Infection. Antimicrob. Agents Chemother.
46: 3499-3505
[Abstract]
[Full Text]